BRIEF-Adocia and Lilly initiate a new phase 1b study of BioChaperone Lispro
September 30, 2015 at 01:35 AM EDT
* Adocia and Eli Lilly and Company initiate a new phase 1b study of repeat administration of ultra-rapid BioChaperone Lispro in patients with type 2 diabetes
